Wednesday, July 8, 2026

pharma · Acute Pain · Pharmacokinetics · ENSC

Ensysce Biosciences

Ensysce Biosciences is a pharma organization headquartered in La Jolla, USA. It trades on NYSE under ticker ENSC. Primary therapeutic focus areas include Acute Pain, Pharmacokinetics, Postoperative Pain, Acute, Recreatio

La Jolla, USA HQ
2008 Founded
13 Employees
Public company Type
ENSC · NYSE Ticker
Company details
Status
Public
HQ
La Jolla, USA
Founded
2008
Employees
13
Programs
6
Drugs
2
Patents
2
Clinical program

PF614

Phase 1 · small molecule · Healthy

PF614 for Healthy is a Phase 1 program (small_molecule) at Ensysce Biosciences with 1 ClinicalTrials.gov record(s).

← All Ensysce Biosciences projects Phase 1 small molecule completed

Internal code PF614-101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Ensysce Biosciences
Phase
Phase 1
Modality
small_molecule
Indication
Healthy
Status
completed
Trials
1

Clinical trials